RU486 inhibits expression of lysophosphatidic acid induced glycodelin

American Journal of Obstetrics and Gynecology

Volumn 192, Issue 4, 2005, Pages 1285-1293

  Ramachandran, Sumathi ^a   Song, Ming Qing ^a   Lowe, Erin ^a   Dominguez, Celia E ^a   Parthasarathy, Sampath ^a   Murphy, Ana A ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis; Antioxidant; Glycodelin; Lysophosphatidic acid; Macrophage; RU486

Indexed keywords

11BETA (4 ACETYLPHENYL) 17BETA HYDROXY 17ALPHA (1 PROPYNYL)ESTRA 4,9 DIEN 3 ONE; LYSOPHOSPHATIDIC ACID; MESSENGER RNA; MIFEPRISTONE; PLACENTA PROTEIN 14; PROGESTERONE;

ANTIOXIDANT ACTIVITY; CONFERENCE PAPER; CONTROLLED STUDY; DRUG ACTIVITY; DRUG INHIBITION; GENE EXPRESSION; HISTIOCYTE; HUMAN; HUMAN CELL; INCUBATION TIME; LEIOMYOMA; MYOMETRIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; UTERUS CONTRACTION;

EID: 16844376808     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2004.12.084     Document Type: Conference Paper

References (33)

1. M. Seppala, H. Koistinen, and R. Koistinen Glycodelins Trends Endocrinol Metab 12 2000 111 117
2. S. Parthasarathy, A.J. Morales, and A.A. Murphy Antioxidant: a new role for RU-486 and related compounds J Clin Invest 94 1994 1990 1995
3. D.P. McDonnell, and M.E. Goldman RU486 exerts antiestrogenic activities through a novel progesterone receptor A form-mediated mechanism J Biol Chem 269 1994 11945 11949
4. A.A. Murphy, L. Kettel, A.J. Morales, V.J. Roberts, and S.S.C. Yen Regression of uterine leiomyomata in response to the antiprogesterone RU 486 J Clin Endocrinol Metab 76 1992 513 517
5. A.A. Murphy, A.J. Morales, L.M. Kettel, and S.S.C. Yen Regression of uterine leiomyomata to the antiprogesterone RU-486: dose response effect Fertil Steril 64 1995 187 190
6. S.H. Eisenger, S. Meldrum, K. Fiscella, H.D. le Roux, and D.S. Guzick Low-dose mifepristone for uterine leiomyomata Obstet Gynecol 101 2003 243 250
7. R.N. Taylor, J.F. Savouret, C. Vaisse, J.L. Vigne, I. Ryan, and D. Hornung Promegestone (R5020) and mifepristone (RU486) both function as progestational agonists of human glycodelin gene expression in isolated human epithelial cells J Clin Endocrinol Metab 83 1998 4006 4009
8. M. Kamarainin, I. Leivo, R. Koistinen, M. Julkunen, U. Karvonen, and E. Rutanan Normal human ovary and ovarian tumors express glycodelin, a glycoprotein with immunosuppressive and contraceptive properties Am J Pathol 148 1996 1435 1443
9. S.T. Cameron, H.O. Critchley, C.H. Buckley, R.W. Kelly, and D.T. Baird Effect of two antiprogestins (mifepristone and onapristone) on endometrial factors of potential importance for implantation Fertil Steril 67 1997 1046 1053
10. R.N. Taylor, J. Vigne, P. Zhang, P. Hoang, D. Lebovic, and M.D. Mueller Effects of progestins and relaxin on glycodelin gene expression in human endometrial cells Am J Obstet Gynecol 182 2000 841 849
11. S. Ramachandran, R. Rong, and S. Parthasarathy Oxidants and antioxidants affect the expression of glycodelin Free Radic Biol Med 34 2003 818 823
12. S. Ramachandran, S. Ramaswamy, C. Cho, and S. Parthasarathy LPA induces glycodelin gene expression in cancer cells Cancer Lett 177 2002 197 202
13. S. Oehninger, G.F. Clark, A.A. Acosta, and G.D. Hodgen Nature of the inhibitory effect of complex saccharides on the tight binding of human spermatozoa to the human zona pellucida Fertil Steril 63 1991 377 383
14. P.I. Roszkowski, A. Hyc, and J. Malejczyk Natural killer cell activity in patients with ovarian tumors and uterine myomas Eur J Gynaecol Oncol 14S 1993 114 117
15. M. Song, S. Ramaswamy, S. Ramachandran, L.C. Flowers, I.R. Horowitz, J.A. Rock, and S. Parthasarathy Angiogenic role for glycodelin in tumorigenesis Proc Natl Acad Sci U S A 98 2001 9265 9270
16. S.S. Richlin, S. Ramachandran, A. Shanti, A.A. Murphy, and S. Parthasarathy Glycodelin levels in uterine flushings and in plasma of patients with leiomyomas and polyps: implications for implantation Hum Reprod 17 2000 2742 2747
17. A.A. Murphy, W. Palinski, S. Rankin, A.J. Morales, and S. Parthasarathy Evidence for oxidatively modified lipid-protein complexes in endometrium and endometriosis Fertil Steril 69 1998 1092 1094
18. R. Adany, F. Fodor, P. Molnar, R.J. Ablin, and L. Muszbek Increased density of histiocytes in uterine leiomyomas Int J Gynecol Pathol 9 1990 137 144
19. I. Sozen, L.M. Senturk, and A. Arici Effect of gonadotropin-releasing hormone agonists on monocyte chemotactic protein-1 production and macrophage infiltration in leiomyomatous uterus Fertil Steril 76 2001 792 796
20. K. Van Oostveldt, C. Burvenich, F.M. Da Silva, and A.M. Massart-Leen Respiratory burst activity in activated and unstimulated isolated bovine blood neutrophils during experimentally induced Escherichia coli mastitis J Dairy Res 66 1999 375 383
21. C.W. Chow, S. Grinstein, and O.D. Rotstein Signaling events in monocytes and macrophages. Signaling events in monocytes and macrophages [Review] New Horizons 3 1995 342 351
22. E.J. Baker, A.T. Ichiki, J.W. Hodge, D. Sugantharaj, E.G. Bamberger, and C.B. Lozzio PMA-treated K-562 leukemia cells mediate a TH2-specific expansion of CD4+ T cells in vitro Leuk4 Res 24 2000 1049 1057
23. P. Xie, F.S.L. Chan, N.Y. Ip, and M. Leung Nerve growth factor potentiated the sodium butyrate and PMA induced megakaryocyte differentiation of K562 leukemia cells Leuk Res 24 2000 751 759
24. E. Vegeto, G. Pollio, C. Pellicciari, and A. Maggi Estrogen and progesterone induction of survival of monoblastoid cells undergoing TNF-α induced apoptosis FASEB 13 1999 793 803
25. T.A. Henderson, P.K. Saunders, A. Moffett-King, N.P. Goome, and H. Critchley Steroid receptor expression in uterine NK cells J Clin Endocrinol Metab 88 2003 440 449
26. C. Agius, and A.S. Gidari Identification of a glucocorticoid receptor in the human leukemia cell line K562 Lab Clin Med 100 1982 178 185
27. T.A. Jackson, J.K. Richer, D.L. Bain, G.S. Takimoto, L. Tung, and K.B. Horowitz The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the core-pressors N-Cor or SMRT Mol Endocrinol 11 1997 693 697
28. Y.L. Hu, M.K. Tee, E.J. Goetzl, N. Auersperg, G.B. Mills, N. Ferrara, and R.B. Jaffe Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells J Natl Cancer Inst 93 2001 762 767
29. J. Chen, M. Chai, and J. Song Regulation of protein kinase C in A-549 cells by phorbol ester Sheng Wu Hua Xue Yu 32 2000 645 648
30. M. Fueller, D.A. Wang, G. Tigyi, and W. Siess Activation of human monocytic cells by LPA and S-1P Cell Signal 15 2003 367 375
31. S. Han, and N. Sidell RU486-induced growth inhibition of human endometrial cells involves the nuclear factor-kappa B signaling pathway J Clin Endocrinol Metab 88 2003 713 719
32. O. Heikenheimo, K. Kontula, H. Croxatto, I. Sptiz, T. Luukkainin, and P. Lahteenmaki Plasma concentration and receptor binding of RU 486 and its metabolities in humans J Steroid Biochem 26 1987 279 284
33. S.A. Leonhardt, V. Boonyaratanakornkit, and D.P. Edwards Progesterone receptor transcription and non-transcription signaling mechanisms Sterioid 68 2003 761 770